Abstract
Actinobacteria are well-known producers of metabolites with medicinal value. The application of actinobacterial compounds has been expanded to other fields, including agriculture, aquaculture, and cosmeceutical. With this, the term “Modern Actinobacteria” (MOD-ACTINO) was first coined by a Malaysian researcher, Associate Professor Dr. Lee Learn Han, to define actinobacteria with modern applications. The present review aims to highlight the MOD-ACTINO research achievements in Malaysia. The Malaysian MOD-ACTINO strains are capable of exerting a wide range of bioactivities such as antimicrobial/anti-MRSA, anticancer, antioxidant, antifungal, and antimalarial. Research on MOD-ACTINO is highly encouraged to harness the benefits of actinobacteria and unravel important metabolites for various applications.
| Original language | English |
|---|---|
| Article number | a0000275 |
| Journal | Progress in Microbes and Molecular Biology |
| Volume | 5 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 20 Jan 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 14 Life Below Water
Free Keywords
- Actinomycetes
- Anticancer
- Antimicrobial
- Antioxidant
- Drug discovery
- Modern actinobacteria
- Streptomycetes
ASJC Scopus subject areas
- Molecular Biology
- Microbiology (medical)
- Microbiology
- Biochemistry, Genetics and Molecular Biology (miscellaneous)
Fingerprint
Dive into the research topics of 'Malaysia’s breakthrough in modern actinobacteria (Mod-actino) drug discovery research'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver